naltrexone protective_against binge eating

Subject: naltrexone
Relation: protective_against
Object: binge eating
p-value: —

Evidence from: primary | all sources

Evidence (2 sources)

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021) PMID:32064741 primary

administration of Naltrexone ... has been shown to reduce the frequency of binge-eating episodes

confidence: 0.90

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021) PMID:32064741 primary

administration of Naltrexone ... has been shown to reduce the frequency of binge‑eating episodes among individuals with an eating disorder

confidence: 0.94